. 2023 Aug;35(8):e13318.

doi: 10.1111/jne.13318. Epub 2023 Aug 14.

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

Johannes Hofland¹, Massimo Falconi², Emanuel Christ^{3

4}, Justo P Castaño^{5

6

7

8}, Antongiulio Faggiano⁹, Angela Lamarca^{10

11}, Aurel Perren¹², Simona Petrucci^{13

14}, Vikas Prasad¹⁵, Philippe Ruszniewski¹⁶, Christina Thirlwell¹⁷, Marie-Pierre Vullierme¹⁸, Staffan Welin¹⁹, Detlef K Bartsch²⁰

Affiliations

¹ Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
² Pancreatic Surgery and Transplantation Unit, Pancreas Translational and Clinical Research Centre, ENETS Center of Excellence, San Raffaele Scientific Institute IRCCS, Milan, Italy.
³ ENETS Centre of Excellence for Neuroendocrine and Endocrine Tumours, University Hospital Basel, Basel, Switzerland.
⁴ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
⁵ Maimonides Biomedical Research Institute of Córdoba, Córdoba, Spain.
⁶ Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain.
⁷ Hospital Universitario Reina Sofía, Córdoba, Spain.
⁸ Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain.
⁹ Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Centre of Excellence, Sapienza University of Rome, Rome, Italy.
¹⁰ Department of Oncology - OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
¹¹ Department of Medical Oncology, The Christie NHS Foundation, Manchester, Division of Cancer Sciences, University of Manchester, Manchester, UK.
¹² Institute of Pathology, University of Bern, Bern, Switzerland.
¹³ Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
¹⁴ Medical Genetics and Advanced Cell Diagnostics Unit, Sant Andrea University Hospital, Rome, Italy.
¹⁵ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.
¹⁶ Department of Pancreatology, FHU MOSAIC, Université Paris Cité - APHP Hôpital Beaujon, Clichy, France.
¹⁷ University of Exeter Medical School, University of Exeter, Exeter, UK.
¹⁸ Centre Hospitalier Annecy Genevois (CHANGE), Université Paris-Cité, Praticien Hospitalier Imagerie Médicale, Annecy, France.
¹⁹ Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
²⁰ Department of Visceral, Thoracic and Vascular Surgery, Phillips-University Marburg and University Hospital Gießen Marburg GmbH, Marburg, Germany.

PMID: 37578384
DOI: 10.1111/jne.13318

Free article

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

Johannes Hofland et al. J Neuroendocrinol. 2023 Aug.

Free article

. 2023 Aug;35(8):e13318.

doi: 10.1111/jne.13318. Epub 2023 Aug 14.

Authors

Affiliations

¹ Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
² Pancreatic Surgery and Transplantation Unit, Pancreas Translational and Clinical Research Centre, ENETS Center of Excellence, San Raffaele Scientific Institute IRCCS, Milan, Italy.
³ ENETS Centre of Excellence for Neuroendocrine and Endocrine Tumours, University Hospital Basel, Basel, Switzerland.
⁴ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
⁵ Maimonides Biomedical Research Institute of Córdoba, Córdoba, Spain.
⁶ Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain.
⁷ Hospital Universitario Reina Sofía, Córdoba, Spain.
⁸ Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain.
⁹ Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Centre of Excellence, Sapienza University of Rome, Rome, Italy.
¹⁰ Department of Oncology - OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
¹¹ Department of Medical Oncology, The Christie NHS Foundation, Manchester, Division of Cancer Sciences, University of Manchester, Manchester, UK.
¹² Institute of Pathology, University of Bern, Bern, Switzerland.
¹³ Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
¹⁴ Medical Genetics and Advanced Cell Diagnostics Unit, Sant Andrea University Hospital, Rome, Italy.
¹⁵ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.
¹⁶ Department of Pancreatology, FHU MOSAIC, Université Paris Cité - APHP Hôpital Beaujon, Clichy, France.
¹⁷ University of Exeter Medical School, University of Exeter, Exeter, UK.
¹⁸ Centre Hospitalier Annecy Genevois (CHANGE), Université Paris-Cité, Praticien Hospitalier Imagerie Médicale, Annecy, France.
¹⁹ Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
²⁰ Department of Visceral, Thoracic and Vascular Surgery, Phillips-University Marburg and University Hospital Gießen Marburg GmbH, Marburg, Germany.

PMID: 37578384
DOI: 10.1111/jne.13318

Abstract

This ENETS guidance paper aims to provide practical advice to clinicians for the diagnosis, treatment and follow-up of functioning syndromes in pancreatic neuroendocrine tumours (NET). A NET-associated functioning syndrome is defined by the presence of a clinical syndrome combined with biochemical evidence of inappropriately elevated hormonal levels. Different hormonal syndromes can be encountered in pancreatic NET patients, including insulinoma, gastrinoma as well as the rare glucagonoma, VIPoma, ACTHoma, PTHrPoma, carcinoid syndrome, calcitoninoma, GHRHoma and somatostatinoma. The recommendations provided in this paper focus on the biochemical, genetic and imaging work-up as well as therapeutic management of the individual hormonal syndromes in well-differentiated, grade 1-3, functioning NET with the primary tumour originating in the pancreas, and for specific subtypes also in the duodenum.

Keywords: ENETS; VIPoma; gastrinoma; guideline; insulinoma; neuroendocrine tumour.

PubMed Disclaimer

Cited by

Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B₁₂ Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.
Ito T, Ramos-Alvarez I, Jensen RT. Ito T, et al. Int J Mol Sci. 2024 Jul 2;25(13):7286. doi: 10.3390/ijms25137286. Int J Mol Sci. 2024. PMID: 39000391 Free PMC article.
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors.
Tobias J, Clarke CN, Gangi A, Keutgen XM. Tobias J, et al. Ann Surg Oncol. 2025 Jul;32(7):4720-4728. doi: 10.1245/s10434-025-17390-x. Epub 2025 May 3. Ann Surg Oncol. 2025. PMID: 40319207 Free PMC article. Review.
Molecular Basis of Pancreatic Neuroendocrine Tumors.
Maluchenko A, Maksimov D, Antysheva Z, Krupinova J, Avsievich E, Glazova O, Bodunova N, Karnaukhov N, Feidorov I, Salimgereeva D, Voloshin M, Volchkov P. Maluchenko A, et al. Int J Mol Sci. 2024 Oct 14;25(20):11017. doi: 10.3390/ijms252011017. Int J Mol Sci. 2024. PMID: 39456803 Free PMC article. Review.
[Premalignant cystic neoplasms and neuroendocrine tumors of the pancreatic head-Is the Kausch-Whipple resection an adequate treatment?].
Beger HG. Beger HG. Chirurgie (Heidelb). 2024 Jun;95(6):461-465. doi: 10.1007/s00104-024-02070-5. Epub 2024 Apr 3. Chirurgie (Heidelb). 2024. PMID: 38568302 Free PMC article. Review. German.
Pancreatic Neuroendocrine Tumors-Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report.
Popa SG, Golli AL, Matei CF, Sonei AN, Vere C, Cimpeanu R, Munteanu M, Munteanu A. Popa SG, et al. Diagnostics (Basel). 2025 Jan 31;15(3):337. doi: 10.3390/diagnostics15030337. Diagnostics (Basel). 2025. PMID: 39941267 Free PMC article.

See all "Cited by" articles

References

REFERENCES

1. Falconi M, Eriksson B, Kaltsas G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153-171.
1. Jensen RT, Cadiot G, Brandi ML, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98-119.
1. Sorbye H, Grande E, Pavel M, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. J Neuroendocrinol. 2023;35:e13249.
1. de Mestier L, Hentic O, Cros J, et al. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study. Ann Intern Med. 2015;162:682-689.
1. Crona J, Norlen O, Antonodimitrakis P, Welin S, Stalberg P, Eriksson B. Multiple and secondary hormone secretion in patients with metastatic pancreatic neuroendocrine Tumours. J Clin Endocrinol Metab. 2016;101:445-452.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

Affiliations

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

Authors

Affiliations

Abstract

Similar articles

Cited by

References

REFERENCES

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

References

REFERENCES

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical